May 2024

Design Freeze for CardioClin 3.0

The recent design freeze for CardioClin marks an important milestone for HeartForce in advancing towards commercialization and regulatory approval. Following extensive clinical research involving over 4,000 patients and valuable input from healthcare experts, the latest iteration of CardioClin has undergone meticulous redesign to improve its user-friendliness and features.

Additionally, our exclusive core technology has been seamlessly integrated into the CardioClin. our medical device now incorporates Bluetooth 5.4 for smooth compatibility with our intuitive Android and iOS applications, enabling real-time monitoring and more effective data gathering.

Back to News